
[Cancer Research 54, 3703-3709, July 15, 1994]
© 1994 American Association for Cancer Research
Frequent p53 Gene Mutations and Novel Alleles in Familial Breast Cancer1
Oleg K. Glebov,
Katherine E. McKenzie,
Christine A. White and
Saraswati Sukumar2
Salk Institute for Biological Studies, La Jolla, California 92037 [O. K. G., K. E. M., C. A. W., S. S.]; Scripps Memorial Hospitals Oncology Research Program, Encinitas, CA 92023 [C. A. W.]
Mutations in the p53 gene were detected in 58% of tumor DNAs of patients with a family history of breast cancer (FHBC) compared to 13% with sporadic breast cancer. Seven of 18 FHBC tumors contained the same G to C transversion in codon 156. Novel alleles of altered length were seen in one or more loci on chromosome 17 in 15 of 18 patients with FHBC but only in a single locus in 8 of 14 patients with sporadic breast cancer. The frequency of tumors with mutations in p53, often multiple, accompanied by the appearance of multiple altered-length alleles suggest that DNA replication or repair defects may presage genomic instability in cases with FHBC.
1 This work was supported by USPHS Grants CA48943, CA57993, and ESO06094 and grants from the Foundation of Medical Research, Inc. (to S. S.).
2 To whom requests for reprints should be addressed, at Salk Institute for Biological Studies, Molecular Biology of Breast Cancer Laboratory, 10010 N. Torrey Pines Rd., La Jolla, CA 92037.
Received 4/19/94.
Accepted 5/26/94.
This article has been cited by other articles:

|
 |

|
 |
 
P Vahteristo, S Ojala, A Tamminen, J Tommiska, H Sammalkorpi, S Kiuru-Kuhlefelt, H Eerola, L A Aaltonen, K Aittomaki, and H Nevanlinna
No MSH6 germline mutations in breast cancer families with colorectal and/or endometrial cancer
J. Med. Genet.,
April 1, 2005;
42(4):
e22 - e22.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Ashur-Fabian, A. Avivi, L. Trakhtenbrot, K. Adamsky, M. Cohen, G. Kajakaro, A. Joel, N. Amariglio, E. Nevo, and G. Rechavi
Evolution of p53 in hypoxia-stressed Spalax mimics human tumor mutation
PNAS,
August 17, 2004;
101(33):
12236 - 12241.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. E. Buller, T. A. Lallas, M. S. Shahin, A. K. Sood, M. Hatterman-Zogg, B. Anderson, J. I. Sorosky, and P. A. Kirby
The p53 Mutational Spectrum Associated with BRCA1 Mutant Ovarian Cancer
Clin. Cancer Res.,
April 1, 2001;
7(4):
831 - 838.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. VAURS-BARRIÈRE, F. PENAULT-LLORCA, V. LAPLACE-MARIEZE, N. PRESNEAU, C. M MAUGARD, M. FICHE, A. HARDOUIN, and Y.-J. BIGNON
Low frequency of microsatellite instability in BRCA1 mutated breast tumours
J. Med. Genet.,
October 1, 2000;
37(10):
32e - 32.
[Full Text]
|
 |
|

|
 |

|
 |
 
J. Lukas, N. Niu, and M. F. Press
p53 Mutations and Expression in Breast Carcinoma in Situ
Am. J. Pathol.,
January 1, 2000;
156(1):
183 - 191.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-A. Phillips, I. L. Andrulis, and P. J. Goodwin
Breast Carcinomas Arising in Carriers of Mutations in BRCA1 or BRCA2: Are They Prognostically Different?
J. Clin. Oncol.,
November 1, 1999;
17(11):
3653 - 3663.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. E. Johnson, G. K. Kovvali, S. N. Guzder, N. S. Amin, C. Holm, Y. Habraken, P. Sung, L. Prakash, and S. Prakash
Evidence for Involvement of Yeast Proliferating Cell Nuclear Antigen in DNA Mismatch Repair
J. Biol. Chem.,
November 8, 1996;
271(45):
27987 - 27990.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Johnson, G. Kovvali, L Prakash, and S Prakash
Requirement of the yeast RTH1 5' to 3' exonuclease for the stability of simple repetitive DNA
Science,
July 14, 1995;
269(5221):
238 - 240.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Futreal, Q Liu, D Shattuck-Eidens, C Cochran, K Harshman, S Tavtigian, L. Bennett, A Haugen-Strano, J Swensen, Y Miki, et al.
BRCA1 mutations in primary breast and ovarian carcinomas
Science,
October 7, 1994;
266(5182):
120 - 122.
[Abstract]
[PDF]
|
 |
|
Copyright © 1994 by the American Association for Cancer Research.